
Dante Omics is a global genomics and precision medicine company founded in 2016 by two Italian co-founders. The company's mission is to make genomics accessible for everyone by leveraging whole genome sequencing technology and variant interpretation to inform health decisions. They offer a wide range of services including Whole Exome Sequencing, Whole Genome Sequencing, Transcriptomics, Proteomics, and specialized services for Oncology, Drug Discovery, and Longevity. Dante Omics utilizes AI and proprietary software like AVANTI for data analysis and interpretation, aiming to accelerate scientific discovery and deliver better healthcare. They have processed millions of COVID samples and serve customers across 97 countries, emphasizing a holistic approach from sequencing to drug development.

Dante Omics is a global genomics and precision medicine company founded in 2016 by two Italian co-founders. The company's mission is to make genomics accessible for everyone by leveraging whole genome sequencing technology and variant interpretation to inform health decisions. They offer a wide range of services including Whole Exome Sequencing, Whole Genome Sequencing, Transcriptomics, Proteomics, and specialized services for Oncology, Drug Discovery, and Longevity. Dante Omics utilizes AI and proprietary software like AVANTI for data analysis and interpretation, aiming to accelerate scientific discovery and deliver better healthcare. They have processed millions of COVID samples and serve customers across 97 countries, emphasizing a holistic approach from sequencing to drug development.